The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow

Saved in:
Bibliographic Details
Published inLeukemia Vol. 20; no. 7; pp. 1319 - 1321
Main Authors Ingram, W, Lea, N C, Cervera, J, Germing, U, Fenaux, P, Cassinat, B, Kiladjian, J J, Varkonyi, J, Antunovic, P, Westwood, N B, Arno, M J, Mohamedali, A, Gaken, J, Kontou, T, Czepulkowski, B H, Twine, N A, Tamaska, J, Csomer, J, Benedek, S, Gattermann, N, Zipperer, E, Giagounidis, A, Garcia-Casado, Z, Sanz, G, Mufti, G J
Format Journal Article Publication
LanguageEnglish
Published England Nature Publishing Group 01.07.2006
Subjects
Adult
Aged
Aged, 80 and over
Bone marrow
Bone Marrow - pathology
Cell Division
Chromosome Deletion
Chromosomes, Human, Pair 5
Female
Gene deletion
Genetic Markers
Humans
Janus kinase 2
Janus Kinase 2 - genetics
Male
MEDICIN
MEDICINE
Middle Aged
Mutation
Myeloproliferative Disorders - classification
Myeloproliferative Disorders - genetics
Myeloproliferative Disorders - pathology
Point Mutation
Subgroups
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0887-6924
1476-5551
1476-5551
DOI:10.1038/sj.leu.2404215